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Background
Objectives
Intervention
Preliminary Conclusions
Disclosure
Study design
• Ongoing multicenter, pre-post study intervention 
across eight emergency departments of a large 
healthcare system
Population:
• All Providence emergency department prescribers in 
the Oregon region
Intervention Period
• Intervention created in accordance with Joint 
Commission standards
• Preliminary data includes pre-intervention period 
between October – December 2019, 
implementation period in January, and post-
intervention data between February-March 2020
Intervention Material
• Data: total and monthly number of all encounters, 
encounters in which any antibiotic was prescribed, 
encounters in which a FQ was prescribed, FQ rate per 
100 antibiotic encounters
• Education materials distributed to providers: 
updated guideline recommendations and 
relevant clinical pearls
Statistics
• Paired T-test
• McNemar Test
1. CDC. Measuring Outpatient Antibiotic Prescribing. CDC. 2019.
2. Opportunities to Improve Fluoroquinolone Prescribing in the 
United States for Adult Ambulatory Care Visits. Clin Infect 
Dis. 2018; 67(1):134-136
• The CDC has proclaimed antibiotic resistance to be 
one of the biggest public health challenges of our 
time.
• 60% of antimicrobials are prescribed in the outpatient 
setting, and up to 30% are inappropriate.1
• Fluoroquinolones (FQ) are the third most commonly 
prescribed outpatient antibiotic class in the US.2
• In 2016, the FDA released a safety communication 
emphasizing the judicial use of FQs.
• The Joint Commission has recently extended their 
antimicrobial stewardship requirements to the 
ambulatory healthcare setting.
• Provider audit-and-feedback and education have been 
shown to be among the most effective interventions.
• Auditing requires significant healthcare resources and 
must be continuous to have durable efficacy.
• Best practices and optimized strategies have not yet 
been determined.
• Targeted provider feedback led to an overall 
decrease in FQ prescriptions.
• The preliminary results are encouraging, but more 
data is needed to detect the true impact of the 
intervention and analyze trends.
• Future steps to improve the antimicrobial 
stewardship intervention are to include provider 
feedback with trends and statistics, specific diseases 
where FQs are not recommended (ie. UTI) and 
provide more tools to guide decision making (ie. data 
regarding utility of urine analysis in specific 
populations). 
Purpose
• To evaluate the change in FQ prescribing within 
emergency departments before and after aggregate 
data, peer-comparison, and education material are 
distributed to individual prescribers.
• Preliminary data will evaluate the initial impact of 
the intervention.
Methodology
Primary Objective
• Decrease total number of FQ prescriptions
Secondary Objectives
• Decrease FQ prescribing by individual study site and 
provider
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Preliminary Discussion
• There was a total decrease in both FQ and all antibiotic 
prescriptions in the post-intervention period.
• The numbers of total encounters and FQ encounters 
were significantly reduced after implementation (p-
value <0.001).
• The Pearson correlation coefficient between FQ and all 
antibiotics was 0.25 (low, insignificant correlation, p-
value=0.7516), indicating no observed trends between 
antibiotics and FQs.
• Using a McNemar test to account for relatively low FQ 
prescription volumes, wherein monthly FQs were 
counted in binary units (0 or > 1 FQ prescription) for 
each provider, a statistically significant reduction in FQ 
rates was detected (p-value=0.0084).
• More data points are needed to perform a paired T-
test on FQ rates, which would provide statistical 
analysis on individual prescriber trends.
• There was a decreasing trend in FQ prescriptions each 
month prior to implementation which cannot be 
explained with the current sample size.
• There was a decrease in total FQ rate for individual 
study sites, however more data is needed to perform 
statistical analysis.
Extract antimicrobial 
prescription data from EHR
Synthesize FQ prescriptions 
and trends by site and 
provider
Distribute de-identified 
aggregate data, peer 
comparison, and education 
materials
Record monthly trend and 
statistics
McNemar Test
(p-value=0.0084) Total FQ > 0 Total FQ = 0
Pre 140 (78.2%) 39 (21.8%)
Post 66 (39.3%) 102 (60.7%)
Paired T-test
Differences
(Pre-Post)
95% CI 
Mean Diff. p-values
Total Encounters by 
Provider 310 (289,331) <.0001
Total Encounters by 
FQ prescriptions 2.0 (1.6,2.3) <.0001
Rates
(FQ/Total Encounters) 0.12 (-0.05,0.29) 0.1778
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